[Solved]: Q.E., a 57-year-old white woman with a medical…

Q.E., a 57-year-old white woman with a medical history significant for breast cancer, completed a 6-cycle regimen of chemotherapy including doxorubicin, docetaxel, and cyclophosphamide less than 1 week ago. She feels fatigued, which her oncologist attributes to the recent chemotherapy. Out of an abundance of caution, Q.E. is referred to a cardiologist who performs a laboratory assessment and ECHO that resulted in an NT-proBNP of 390 pg/mL [reference range <125 pg/mL] and a left ventricular ejection fraction (LVEF) of 58% and no identifiable abnormalities. Q.E. denies any symptoms of heart failure (HF) and reports being able to complete her normal activities of daily life without limitations. Which one of the following best evaluates QE with respect to the Heart Failure Society of America (HFSA). Heart Failure Association of the European Society of cardiology (HFA-ESC), and the Japanese Heart Failure Society (JHFS) staging system and New York Heart Association (NYHA) Functional classification? At risk of HF and NYHA class I At risk for HF with no accompanying NYHA classfication Pre-HF and NYHA Class I Pre-HF with no accompanying NYHA classification